Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

INDONESIA: Indonesia Licenses Patents for Seven HIV & Hepatitis B Medicines


InfoJustice (10.11.12)

On September 3, Indonesia’s President Dr. H. Susilo Bambang Yudhoyono signed a decree authorizing the government’s use of patents for seven HIV/AIDS and hepatitis medicines. By doing so, the Indonesian government expanded access to medicines that will help save and improve the lives of people with HIV/AIDS and hepatitis B. If fully implemented, the measure will introduce widespread generic competition and generate major cost savings in the world’s fourth most populous country. The decree licenses patents for several HIV medicines, and represents one of the most robust uses of pharmaceutical patent licensing power by a country since the World Trade Organization’s 1995 Agreement on Trade-Related Aspects of Intellectual Property Rights. The presidential decree greatly expands Indonesia’s access to newer and more appropriate antiviral and antiretroviral treatments, including efavirenz, abacavir, didanosin, lopinavir + ritonavir, tenofovir, tenofovir + emtricitabine, and tenofovir + emtricitabine + efavirenz. For more information, including a copy of the decree (in Indonesian and an unofficial English translation), analysis, a table of the licensed medicines, and Indonesia’s response to HIV and hepatitis B, visit


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in October 12, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.